James Darecca - Net Worth and Insider Trading

James Darecca Net Worth

The estimated net worth of James Darecca is at least $4,186 dollars as of 2024-09-23. James Darecca is the CFO of TherapeuticsMD Inc and owns about 2,477 shares of TherapeuticsMD Inc (TXMD) stock worth over $4,186. Details can be seen in James Darecca's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Darecca has not made any transactions after 2021-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Darecca

To

James Darecca Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Darecca owns 3 companies in total, including TherapeuticsMD Inc (TXMD) , Haemonetics Corp (HAE) , and Prestige Consumer Healthcare Inc (PBH) .

Click here to see the complete history of James Darecca’s form 4 insider trades.

Insider Ownership Summary of James Darecca

Ticker Comapny Transaction Date Type of Owner
TXMD TherapeuticsMD Inc 2021-08-12 Chief Financial Officer
HAE Haemonetics Corp 2022-04-11 EVP & Chief Financial Officer
PBH Prestige Consumer Healthcare Inc 2023-08-01 director

James Darecca Latest Holdings Summary

James Darecca currently owns a total of 1 stock. James Darecca owns 2,477 shares of TherapeuticsMD Inc (TXMD) as of August 12, 2021, with a value of $4,186.

Latest Holdings of James Darecca

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TXMD TherapeuticsMD Inc 2021-08-12 2,477 1.69 4,186

Holding Weightings of James Darecca


James Darecca Form 4 Trading Tracker

According to the SEC Form 4 filings, James Darecca has made a total of 1 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TherapeuticsMD Inc is the sale of 1,867 shares on August 12, 2021, which brought James Darecca around $81,203.

Insider Trading History of James Darecca

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Darecca Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Darecca Ownership Network

Ownership Network List of James Darecca

No Data

Ownership Network Relation of James Darecca

Insider Network Chart

James Darecca Owned Company Details

What does TherapeuticsMD Inc do?

Who are the key executives at TherapeuticsMD Inc?

James Darecca is the Chief Financial Officer of TherapeuticsMD Inc. Other key executives at TherapeuticsMD Inc include General Counsel Marlan D Walker , Principal Financial Officer Joseph Ziegler , and CAO and VP of Finance Michael C Donegan .

TherapeuticsMD Inc (TXMD) Insider Trades Summary

Over the past 18 months, James Darecca made no insider transaction in TherapeuticsMD Inc (TXMD). Other recent insider transactions involving TherapeuticsMD Inc (TXMD) include a net sale of 20,912 shares made by Marlan D Walker , and a net purchase of 5,294 shares made by Collins Cooper C. .

In summary, during the past 3 months, insiders sold 0 shares of TherapeuticsMD Inc (TXMD) in total and bought 5,294 shares, with a net purchase of 5,294 shares. During the past 18 months, 20,912 shares of TherapeuticsMD Inc (TXMD) were sold and 5,294 shares were bought by its insiders, resulting in a net sale of 15,618 shares.

TherapeuticsMD Inc (TXMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TherapeuticsMD Inc Insider Transactions

No Available Data

James Darecca Mailing Address

Above is the net worth, insider trading, and ownership report for James Darecca. You might contact James Darecca via mailing address: C/o Haemonetics Corporation, 125 Summer Street, Boston Ma 02110.

Discussions on James Darecca

No discussions yet.